Vitrakvi - NDC Database


6 records found:

Sorted by NDC Code

Page of 1
50419-390 Jul 26, 2019
Vitrakvi 25 mg Oral Capsule by Bayer Healthcare Pharmaceuticals Inc.
50419-391 Jul 26, 2019
Vitrakvi 100 mg Oral Capsule by Bayer Healthcare Pharmaceuticals Inc.
50419-392 Jul 26, 2019
Vitrakvi 20 mg/ml Oropharyngeal Solution, Concentrate by Bayer Healthcare Pharmaceuticals Inc.
71777-390 Nov 26, 2018
Vitrakvi 25 mg Oral Capsule by Loxo Oncology, Inc.
71777-391 Nov 26, 2018
Vitrakvi 100 mg Oral Capsule by Loxo Oncology, Inc.
71777-392 Nov 26, 2018
Vitrakvi 20 mg/ml Oral Solution by Loxo Oncology, Inc.

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 4 April 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA